Thyrocare Technologies Limited has informed the Exchange about Schedule of meet
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies has informed the stock exchanges about an upcoming earnings conference call scheduled for Wednesday, July 23, 2025, at 5:00 PM IST. The call will be held to discuss the company's unaudited financial results for the quarter ended June 30, 2025 (Q1FY26). Senior management including MD & CEO Rahul Guha, CFO Alok Kumar Jagnani, and Chief Commercial Officer Nitin Chugh will interact with analysts and investors. Dial-in numbers and a webcast link have been shared for participants. The disclosure is made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine advance notice of an earnings call and contains no financial numbers, so it is unlikely to move the stock on its own. Investors should watch the July 23 call for actual Q1FY26 performance, growth in diagnostics volumes, and margin commentary from the new leadership team.